课题基金 / 基金详情

BROMODEOXYURIDINE AND RADIATION THERAPY INVOLVING THE LIVER

BROMODEOXYURIDINE AND RADIATION THERAPY INVOLVING THE LIVER
溴脱氧尿苷和涉及肝脏的放射治疗
批准号：
5217604
负责人：
JOHN M ROBERTSON
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5217604
关键词：
bromodeoxyuridine clinical research clinical trial phase I combination cancer therapy human subject human therapy evaluation liver neoplasms neoplasm /cancer radiation therapy

项目摘要

项目成果

JOHN M ROBERTSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a Phase I protocol for patients with cancer involving the liver and porta hepatis using escalating dose rates of BUdR, a thymidine analog radiosensitizer, combined with hyperfractionated external beam irradiation. Radiation dose is determined through the use of three dimensional treatment planning techniques and is based on the volume of normal liver spared, in a manner identical to a previous version of 719 (however, the radiation doses have been decreased in this current protocol).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BROMODEOXYURIDINE AND RADIATION FOR CANCER OF LIVER AND/OR BILE DUCTS
BROMODEOXYURIDINE AND RADIATION FOR CANCER OF LIVER AND/OR BILE DUCTS
BROMODEOXYURIDINE AND RADIATION FOR CANCER OF LIVER AND/OR BILE DUCTS
IV FLUORODEOXYURIDINE AND RADIATION THERAPY
  • 批准号：
    5216213
  • 项目类别：
  • 资助金额：
    $0.0万
  • 财政年份：
    --
  • 负责人：
    JOHN M ROBERTSON
  • 依托单位：
    --
海外基金